Maximus, Inc. $MMS Shares Purchased by Allianz Asset Management GmbH

Allianz Asset Management GmbH boosted its holdings in Maximus, Inc. (NYSE:MMS) by 16.7% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 272,204 shares of the health services provider’s stock after purchasing an additional 38,856 shares during the quarter. Allianz Asset Management GmbH’s holdings in Maximus were worth $24,871,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of MMS. Richardson Financial Services Inc. increased its holdings in shares of Maximus by 123.1% in the 3rd quarter. Richardson Financial Services Inc. now owns 348 shares of the health services provider’s stock valued at $32,000 after acquiring an additional 192 shares during the last quarter. Canada Pension Plan Investment Board acquired a new position in Maximus in the second quarter valued at approximately $35,000. Cullen Frost Bankers Inc. purchased a new position in Maximus in the third quarter valued at approximately $38,000. Bayforest Capital Ltd acquired a new stake in Maximus during the second quarter worth approximately $61,000. Finally, Parkside Financial Bank & Trust lifted its position in shares of Maximus by 21.7% during the 2nd quarter. Parkside Financial Bank & Trust now owns 879 shares of the health services provider’s stock worth $62,000 after buying an additional 157 shares during the last quarter. 97.21% of the stock is owned by hedge funds and other institutional investors.

Maximus News Summary

Here are the key news stories impacting Maximus this week:

• Positive Sentiment: Q1 EPS narrowly beat expectations — Maximus reported $1.85 EPS vs. the $1.84 consensus, showing earnings strength and year‑over‑year EPS improvement. Maximus (MMS) Q1 Earnings Top Estimates
• Positive Sentiment: Margins improved — management emphasized margin gains and cost discipline during the call, which supports near‑term profitability despite revenue pressure. Maximus Earnings Call: Margins Rise Amid Revenue Pressure
• Neutral Sentiment: Full disclosure and investor materials posted — the company released the press release, slide deck and earnings‑call transcript for detailed review (useful for modeling/QA but not market moving by itself). View Press Release / Slide Deck
• Negative Sentiment: Revenue miss and YoY decline — Q1 revenue was $1.35B vs. ~$1.37B expected and fell ~4.1% year‑over‑year, signaling near‑term top‑line weakness. Maximus Q1 results and materials
• Negative Sentiment: Tightened / lower FY‑2026 revenue guidance — management set FY‑2026 revenue of $5.2B–$5.4B (below Street ~ $5.5B) and EPS guidance of $8.05–$8.35 (around but slightly below consensus midpoint), which pressured growth expectations. Maximus tops Q1 earnings forecasts while tightening 2026 revenue guidance

Insiders Place Their Bets

In other Maximus news, insider Michelle F. Link sold 4,039 shares of the stock in a transaction that occurred on Wednesday, December 3rd. The stock was sold at an average price of $86.84, for a total transaction of $350,746.76. Following the completion of the sale, the insider directly owned 19,542 shares of the company’s stock, valued at approximately $1,697,027.28. This trade represents a 17.13% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.80% of the company’s stock.

Maximus Stock Down 3.9%

MMS stock opened at $75.17 on Friday. The company has a market cap of $4.10 billion, a price-to-earnings ratio of 11.44 and a beta of 0.57. The company has a fifty day moving average price of $90.07 and a 200 day moving average price of $86.38. The company has a debt-to-equity ratio of 0.88, a current ratio of 2.34 and a quick ratio of 1.64. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $100.00.

Maximus (NYSE:MMS) last posted its quarterly earnings data on Thursday, February 5th. The health services provider reported $1.85 EPS for the quarter, beating analysts’ consensus estimates of $1.84 by $0.01. Maximus had a net margin of 6.92% and a return on equity of 25.30%. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.37 billion. During the same period in the previous year, the business posted $1.61 earnings per share. Maximus’s quarterly revenue was down 4.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. Sell-side analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 2nd. Shareholders of record on Friday, February 13th will be paid a dividend of $0.33 per share. The ex-dividend date of this dividend is Friday, February 13th. This represents a $1.32 annualized dividend and a yield of 1.8%. This is a boost from Maximus’s previous quarterly dividend of $0.30. Maximus’s dividend payout ratio (DPR) is currently 21.58%.

Analyst Ratings Changes

MMS has been the subject of several research analyst reports. Zacks Research upgraded shares of Maximus from a “hold” rating to a “strong-buy” rating in a report on Tuesday, December 30th. Weiss Ratings restated a “buy (b-)” rating on shares of Maximus in a research note on Monday, December 29th. Finally, Wall Street Zen lowered Maximus from a “buy” rating to a “hold” rating in a report on Saturday. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Strong Buy”.

Maximus Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.